Valbenazine, sold under the brand name Ingrezza, is a medication used to treat tardive dyskinesia. It acts as a vesicular monoamine transporter 2 (VMAT2)... 12 KB (879 words) - 02:44, 9 March 2024 |
endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia... 15 KB (1,289 words) - 16:36, 15 April 2024 |
Tranylcypromine, Trazodone, Triazolam, Trifluoperazine, Trimipramine Valbenazine, Valproate, Venlafaxine Zaleplon, Zimelidine, Ziprasidone, Zolpidem,... 3 KB (203 words) - 11:32, 30 September 2023 |
inhibitors marketed as drugs including deutetrabenazine, tetrabenazine, and valbenazine. The question of the God Gene could be answered by experimental studies... 9 KB (1,046 words) - 11:06, 4 April 2024 |
include deutetrabenazine, oxypertine, reserpine, tetrabenazine, and valbenazine. Carlsson A (1975). "Monoamine-depleting drugs". Pharmacol Ther B. 1... 2 KB (136 words) - 21:25, 11 March 2024 |